; (V) the net acquisition cost per dosage unit, per 30-day supply, and per 90-day supply, if the drug is subject to a maximum price discount; and (VI) other information with respect to the cost of the drug, as determined by the Secretary, the Secretary of Health and Human Services, and the Secretary of the Treasury, such as average sales price, wholesale acquisition cost, and national average drug acquisition cost per dosage unit or per 30-day supply, for such drug, including amounts charged to the plan or issuer and participants and beneficiaries among all pharmacies included in the network of the plan or coverage; (I) a summary document for plan sponsors or issuers that includes the information described in subparagraphs (A) through (H) that the Secretary, the Secretary of Health and Human Services, and the Secretary of the Treasury determine useful to plan sponsors and health insurance issuers for purposes of selecting pharmacy benefit management services, such as an estimated net price to plan sponsor and participant or beneficiary, a cost per claim, the fee structure or reimbursement model, and estimated cost per participant or beneficiary